651 related articles for article (PubMed ID: 30742092)
1. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition.
Scher JU; Ogdie A; Merola JF; Ritchlin C
Nat Rev Rheumatol; 2019 Mar; 15(3):153-166. PubMed ID: 30742092
[TBL] [Abstract][Full Text] [Related]
2. Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study.
Perez-Chada LM; Haberman RH; Chandran V; Rosen CF; Ritchlin C; Eder L; Mease P; Reddy S; Ogdie A; Merola JF; Scher JU
Nat Rev Rheumatol; 2021 Apr; 17(4):238-243. PubMed ID: 33589818
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of psoriatic arthritis.
Stober C
Best Pract Res Clin Rheumatol; 2021 Jun; 35(2):101694. PubMed ID: 34108102
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis and systemic inflammation: underdiagnosed enthesopathy.
Girolomoni G; Gisondi P
J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():3-8. PubMed ID: 19686379
[TBL] [Abstract][Full Text] [Related]
5. From Psoriasis to Psoriatic Arthritis: Ultrasound Insights Connecting Psoriasis with Subclinical Musculoskeletal Inflammation and the Path to Psoriatic Arthritis.
Ribeiro AL; Eder L
Curr Rheumatol Rep; 2024 Jul; 26(7):235-247. PubMed ID: 38512585
[TBL] [Abstract][Full Text] [Related]
6. Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention.
McHugh NJ
J Rheumatol Suppl; 2015 Nov; 93():10-3. PubMed ID: 26523046
[TBL] [Abstract][Full Text] [Related]
7. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis.
Faustini F; Simon D; Oliveira I; Kleyer A; Haschka J; Englbrecht M; Cavalcante AR; Kraus S; Tabosa TP; Figueiredo C; Hueber AJ; Kocijan R; Cavallaro A; Schett G; Sticherling M; Rech J
Ann Rheum Dis; 2016 Dec; 75(12):2068-2074. PubMed ID: 26916344
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors as a potential new treatment for psoriatic disease and other inflammatory conditions.
Nazri JM; Oikonomopoulou K; de Araujo ED; Kraskouskaya D; Gunning PT; Chandran V
Crit Rev Clin Lab Sci; 2023 Jun; 60(4):300-320. PubMed ID: 36846924
[TBL] [Abstract][Full Text] [Related]
9. Association of Structural Entheseal Lesions With an Increased Risk of Progression From Psoriasis to Psoriatic Arthritis.
Simon D; Tascilar K; Kleyer A; Bayat S; Kampylafka E; Sokolova MV; Zekovic A; Hueber AJ; Rech J; Schuster L; Engel K; Sticherling M; Schett G
Arthritis Rheumatol; 2022 Feb; 74(2):253-262. PubMed ID: 32103639
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies.
Qi F; Tan Y; Yao A; Yang X; He Y
Front Med (Lausanne); 2021; 8():681172. PubMed ID: 34869404
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of psoriatic arthritis.
Veale DJ; Fearon U
Lancet; 2018 Jun; 391(10136):2273-2284. PubMed ID: 29893226
[TBL] [Abstract][Full Text] [Related]
12. Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence.
Ogdie A; Gelfand JM
Curr Rheumatol Rep; 2015 Oct; 17(10):64. PubMed ID: 26290111
[TBL] [Abstract][Full Text] [Related]
13. Immunologic advances reveal new targets in psoriasis and psoriatic arthritis.
Mortezavi M; Ritchlin C
Discov Med; 2015 Oct; 20(110):169-75. PubMed ID: 26562469
[TBL] [Abstract][Full Text] [Related]
14. Innovative Imaging Technique for Visualization of Vascularization and Established Methods for Detection of Musculoskeletal Inflammation in Psoriasis Patients.
Köhm M; Zerweck L; Ngyuen PH; Burkhardt H; Behrens F
Front Med (Lausanne); 2020; 7():468. PubMed ID: 32984365
[TBL] [Abstract][Full Text] [Related]
15. The Microbiome in Psoriasis and Psoriatic Arthritis: The Skin Perspective.
Thio HB
J Rheumatol Suppl; 2018 Jun; 94():30-31. PubMed ID: 29858350
[TBL] [Abstract][Full Text] [Related]
16. Can early treatment with biologicals modify the natural history of comorbidities?
Vena GA; Vestita M; Cassano N
Dermatol Ther; 2010; 23(2):181-93. PubMed ID: 20415826
[TBL] [Abstract][Full Text] [Related]
17. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
Tobin AM; Kirby B
BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics of psoriatic disease: A systematic review and critical appraisal.
Pollock RA; Abji F; Gladman DD
J Autoimmun; 2017 Mar; 78():29-38. PubMed ID: 27965059
[TBL] [Abstract][Full Text] [Related]
19. Nail psoriasis as a predictor of the development of psoriatic arthritis.
Raposo I; Torres T
Actas Dermosifiliogr; 2015; 106(6):452-7. PubMed ID: 26026773
[TBL] [Abstract][Full Text] [Related]
20. The safety of ustekinumab for the treatment of psoriatic arthritis.
López-Ferrer A; Laiz A; Puig L
Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
